CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors

CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors

Abstract Background To validate the utility of the chemokine ligand 12 (CXCL12) as prognostic marker in patients with localized and metastatic germ cell tumors (GCT). Methods CXCL12 expression was analyzed on a tissue microarray consisting of 750 tissue cores of different histological tumor componen...

Full description

Bibliographic Details
Main Authors: Christian Daniel Fankhauser, Lisa Roth, Nico Christian Grossmann, Benedikt Kranzbühler, Daniel Eberli, Tullio Sulser, Holger Moch, Peter-Karl Bode, Joerg Beyer, Thomas Hermanns
Format: Article
Language:English
Published: BMC 2019-08-01
Series:BMC Cancer
Subjects:
Testicular germ cell tumor
Biomarkers, tumor
Prognosis
Online Access:http://link.springer.com/article/10.1186/s12885-019-5961-1

Internet

http://link.springer.com/article/10.1186/s12885-019-5961-1

Similar Items